Context Therapeutics (CNTX)
NASDAQ:CNTX
Holding CNTX?
Track your performance easily

Context Therapeutics (CNTX) Stock Investors

70 Followers
Based on 757,311 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CNTX
On average, investors allocate 0.00% of their portfolios to CNTX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 757,311 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CNTX

13.8%
Last 7
Days
16.3%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CNTX, out of 757,311 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CNTX Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,468 investors who made their portfolios public
The table shows changes in CNTX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CNTX Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.61%
-1.95%
+0.60%
33.45B
Consumer Cyclical
XPeng, Inc. ADR
5.47%
-1.43%
-3.14%
8.60B
Consumer Cyclical
Plug Power
5.12%
-1.16%
-2.94%
1.85B
Industrials
Devon Energy
5.08%
-0.79%
-0.79%
25.28B
Energy
Riot Platforms
4.72%
-1.32%
-1.97%
2.18B
Financial
Lucid Group
5.94%
-0.64%
-0.17%
8.44B
Consumer Cyclical
Blink Charging Co
5.32%
-1.73%
-3.80%
183.08M
Industrials
Coherus Biosciences
2.45%
+0.17%
-1.13%
120.97M
Healthcare
SoFi Technologies
9.99%
-0.09%
-0.10%
8.64B
Financial
PDD Holdings
4.87%
-1.05%
+6.82%
136.42B
Consumer Cyclical
Based on the activity of 757,311 active portfolios
Open your Smart Portfolio

CNTX Investor Analysis

CNTX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
20.0%
of CNTX holders
are under 35
Average Segment Performance
Average P/E Ratio20.16
Beta8.32
Dividend Yield3.50%
CNTX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
53.3%
of CNTX holders
are between 35–55
Average Segment Performance
Average P/E Ratio18.25
Beta13.76
Dividend Yield3.65%
CNTX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
26.7%
of CNTX holders
are over 55
Average Segment Performance
Average P/E Ratio20.06
Beta4.95
Dividend Yield3.36%
Overview of age group and performance of CNTX stock investors
See who invests in CNTX according to age group and performance.

FAQ

How many retail Investors hold CNTX?
<0.1% of TipRanks' retail investors hold CNTX in their portfolios.
    What is CNTX Investor Sentiment?
    CNTX’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of CNTX in the last 7 days?
      ▲ 13.8% of TipRanks' retail investors changed their holding of CNTX in the last 7 days.
        What percentage of retail investors changed their holding of CNTX in the last 30 days?
        ▲ 16.3% of TipRanks' retail investors changed their holding of CNTX in the last 30 days.
          What is the average age of retail investors who hold CNTX?
          The average age of CNTX Holders is between 35–55.
            What other stocks have CNTX investors also bought?
            CNTX Investors also bought DKNG, XPEV, PLUG, DVN, RIOT, LCID, BLNK, CHRS, SOFI, PDD.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              BMRNBioMarin Pharmaceutical
              BSXBoston Scientific
              CPRXCatalyst Pharma
              EXELExelixis
              AVDLAvadel Pharmaceuticals
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis